# Safety, Efficacy, and Short-Term Outcomes of Rezūm Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia Under Local Anesthesia With Intravenous Sedation: A Single-Center Retrospective Study of 129 Patients in the Kurdistan Region of Iraq

> **NCT07507591** · — · COMPLETED · sponsor: **ALI KAMAL M. SAMI** · enrollment: 129 (actual)

## Conditions studied

- Benign Prostate Hyperplasia

## Interventions

- **DEVICE:** Rezum Water Vapor Thermal Therapy

## Key facts

- **NCT ID:** NCT07507591
- **Lead sponsor:** ALI KAMAL M. SAMI
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-03
- **Primary completion:** 2026-03-12
- **Final completion:** 2026-03-12
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07507591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07507591, "Safety, Efficacy, and Short-Term Outcomes of Rezūm Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia Under Local Anesthesia With Intravenous Sedation: A Single-Center Retrospective Study of 129 Patients in the Kurdistan Region of Iraq". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07507591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*